eMedevents
  • 143,049+ Medical Conferences
  • 279 Specialties
  • 10,783 Organizers
  • 153,946 Speakers
  • 156 Countries
  • 4,640 Cities
47,683+
CME Conference Registrations Sold
Home  >  Speakers  >  Victoria Richon
Victoria Richon

Victoria Richon

    PhD
President, Chief Executive Officer | Lexington, Massachusetts    United States of America
Biochemistry And Molecular Genetics
Biochemistry, Oncology,...More
Speaking at 1 event

Biography :

Dr. Richon is a scientifically trained executive with decades of leadership experience in small biotechnology companies, global pharmaceutical companies, and academia. Before joining Ribon, Dr. Richon was the Vice President and Global Head of Oncology Research and Translational Medicine at Sanofi where she led the company’s early oncology efforts.

Prior to Sanofi, Dr. Richon was Vice President of Biological Sciences at Epizyme, Inc., a biotechnology company pioneering therapeutics based upon epigenetics. Earlier in her career, she was Founder and Executive Director of Aton Pharmaceuticals, which was acquired by Merck in 2004. Aton was formed to develop HDAC inhibitors, including vorinostat, an HDAC inhibitor that Dr. Richon developed during her tenure at Sloan-Kettering Cancer Center and vorinostat was the first HDAC inhibitor approved by the FDA while she was at Merck.

Dr. Richon received her Ph.D. in Biochemistry at the University of Nebraska Medical Center and a B.A. in Chemistry at the University of Vermont.

*******************
************
   
For speaker's contact information - Contact us

Specialties

Biochemistry and Molecular Genetics

Interested Topics

Biochemistry, Oncology, Drug Discovery, Biotechnology, Drug Development, Pharmaceutical Industry, Epigenetics, Biomarkers, Assay Development

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message